iPROLEPSIS: PSORIATIC ARTHRITIS INFLAMMATION EXPLAINED THROUGH MULTI-SOURCE DATA ANALYSIS GUIDING A NOVEL PERSONALISED DIGITAL CARE ECOSYSTEM
Psoriatic Arthritis (PsA) is a chronic, progressive, inflammatory disease affecting 1-2% of the general population, while manifesting in up to 30% of people with psoriasis (PsO).
iPROLEPSIS is a HorizonEurope-funded project developing a novel personalised digital care ecosystem for people with PsA.
iPROLEPSIS OBJECTIVES:
iPROLEPSIS consortium works on 7 ambitious key objectives in the field of
Psoriatic Arthritis (PsA):
Discover PsA inflammation drivers through AI-driven health, environmental and omics data mining
Develop and validate objective digital biomarkers for tracking inflammatory symptoms and disease activity
Investigate the role of mast cells and features from non-invasive skin microvascular/joint imaging in inflammatory symptoms tracking
Build trustworthy AI models for personalised PsA risk prediction, early diagnosis and high disease activity prognosis
Develop ICT-based personalised interventions to sustain or even improve quality-of-life
Develop and clinically validate the iPROLEPSIS digital health ecosystem to empower persons with/at risk of PsA and healthcare professionals
Co-create the iPROLEPSIS ecosystem with key stakeholders, following ethical, inclusive and trustworthy AI principles